Protection against cisplatin induced neurotoxicity by ORG 2766: histological and electrophysiological evidence
- 30 November 1994
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 126 (2) , 109-115
- https://doi.org/10.1016/0022-510x(94)90259-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The neurotrophic analogue of ACTH(4–9), Org 2766, protects against experimental allergic neuritisBrain, 1993
- Molecular Cloning of a Novel Human Melanocortin ReceptorBiochemical and Biophysical Research Communications, 1993
- RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II)Biochemistry, 1992
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Org.2766 stimulates collateral sprouting in the soleus muscle of the rat following partial denervationMuscle & Nerve, 1989
- Recovery from Acrylamide Neuropathy is Improved by Treatment with an ACTH Analogue, ORG.2766Human Toxicology, 1989
- Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in ratsEuropean Journal of Cancer and Clinical Oncology, 1988
- Org.2766 protects from cisplatin-induced neurotoxicity in ratsExperimental Neurology, 1987
- Evaluation of cis-diamminedichloroplatinum (II) (cisplatin) neurotoxicity in ratsToxicology and Applied Pharmacology, 1987
- Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects.Physiological Reviews, 1982